Header Logo

Connection

CHAO CHENG to Breast Neoplasms

Back to Details
This is a "connection" page, showing publications CHAO CHENG has written about Breast Neoplasms.
CHAO CHENG
Connection Strength
3.704
Breast Neoplasms
  1. A framework to predict the applicability of Oncotype DX, MammaPrint, and E2F4 gene signatures for improving breast cancer prognostic prediction. Sci Rep. 2022 02 09; 12(1):2211.
    View in: PubMed
    Score: 0.302
  2. Impact of Oncotype DX testing on ER+ breast cancer treatment and survival in the first decade of use. Breast Cancer Res. 2021 07 17; 23(1):74.
    View in: PubMed
    Score: 0.291
  3. Computational Investigation of Homologous Recombination DNA Repair Deficiency in Sporadic Breast Cancer. Sci Rep. 2017 Nov 16; 7(1):15742.
    View in: PubMed
    Score: 0.225
  4. The E2F4 prognostic signature predicts pathological response to neoadjuvant chemotherapy in breast cancer patients. BMC Cancer. 2017 05 02; 17(1):306.
    View in: PubMed
    Score: 0.217
  5. Contextual Refinement of Regulatory Targets Reveals Effects on Breast Cancer Prognosis of the Regulome. PLoS Comput Biol. 2017 01; 13(1):e1005340.
    View in: PubMed
    Score: 0.213
  6. Application of pharmacologically induced transcriptomic profiles to interrogate PI3K-Akt-mTOR pathway activity associated with cancer patient prognosis. Oncotarget. 2016 Dec 20; 7(51):84142-84154.
    View in: PubMed
    Score: 0.212
  7. Application of RNAi-induced gene expression profiles for prognostic prediction in breast cancer. Genome Med. 2016 10 27; 8(1):114.
    View in: PubMed
    Score: 0.210
  8. Adaptive immunity programmes in breast cancer. Immunology. 2017 Jan; 150(1):25-34.
    View in: PubMed
    Score: 0.208
  9. Integrative analysis of breast cancer reveals prognostic haematopoietic activity and patient-specific immune response profiles. Nat Commun. 2016 Jan 04; 7:10248.
    View in: PubMed
    Score: 0.198
  10. Regulators associated with clinical outcomes revealed by DNA methylation data in breast cancer. PLoS Comput Biol. 2015 May; 11(5):e1004269.
    View in: PubMed
    Score: 0.190
  11. Integrative analysis of survival-associated gene sets in breast cancer. BMC Med Genomics. 2015 Mar 12; 8:11.
    View in: PubMed
    Score: 0.187
  12. E2F4 regulatory program predicts patient survival prognosis in breast cancer. Breast Cancer Res. 2014 Dec 02; 16(6):486.
    View in: PubMed
    Score: 0.184
  13. Effect of estrogen receptor a binding on functional DNA methylation in breast cancer. Epigenetics. 2014 Apr; 9(4):523-32.
    View in: PubMed
    Score: 0.173
  14. REACTIN: regulatory activity inference of transcription factors underlying human diseases with application to breast cancer. BMC Genomics. 2013 Jul 26; 14:504.
    View in: PubMed
    Score: 0.167
  15. mRNA expression profiles show differential regulatory effects of microRNAs between estrogen receptor-positive and estrogen receptor-negative breast cancer. Genome Biol. 2009; 10(9):R90.
    View in: PubMed
    Score: 0.128
  16. Systematic identification of transcription factors associated with patient survival in cancers. BMC Genomics. 2009 May 15; 10:225.
    View in: PubMed
    Score: 0.125
  17. MYC Activity Inference Captures Diverse Mechanisms of Aberrant MYC Pathway Activation in Human Cancers. Mol Cancer Res. 2021 03; 19(3):414-428.
    View in: PubMed
    Score: 0.069
  18. CD36-Mediated Metabolic Rewiring of Breast Cancer Cells Promotes Resistance to HER2-Targeted Therapies. Cell Rep. 2019 12 10; 29(11):3405-3420.e5.
    View in: PubMed
    Score: 0.065
  19. A Transcriptionally Definable Subgroup of Triple-Negative Breast and Ovarian Cancer Samples Shows Sensitivity to HSP90 Inhibition. Clin Cancer Res. 2020 01 01; 26(1):159-170.
    View in: PubMed
    Score: 0.064
  20. Molecular and epigenetic profiles of BRCA1-like hormone-receptor-positive breast tumors identified with development and application of a copy-number-based classifier. Breast Cancer Res. 2019 01 25; 21(1):14.
    View in: PubMed
    Score: 0.061
  21. Cytokine sensitivity screening highlights BMP4 pathway signaling as a therapeutic opportunity in ER+ breast cancer. FASEB J. 2019 02; 33(2):1644-1657.
    View in: PubMed
    Score: 0.060
  22. Therapeutically targeting tumor microenvironment-mediated drug resistance in estrogen receptor-positive breast cancer. J Exp Med. 2018 03 05; 215(3):895-910.
    View in: PubMed
    Score: 0.057
  23. Unsupervised feature construction and knowledge extraction from genome-wide assays of breast cancer with denoising autoencoders. Pac Symp Biocomput. 2015; 132-43.
    View in: PubMed
    Score: 0.046
  24. Age-related DNA methylation in normal breast tissue and its relationship with invasive breast tumor methylation. Epigenetics. 2014 Feb; 9(2):268-75.
    View in: PubMed
    Score: 0.043
  25. A comprehensive nuclear receptor network for breast cancer cells. Cell Rep. 2013 Feb 21; 3(2):538-51.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.